Musa M M, Abdoon A M, Nasir B T, Salim Y I, Abdel-Rahman A Y, Shommein A M
Tsetse and Trypanosomiasis Control Department, Central Veterinary Research Administration, Khartoum, Soudan.
Rev Elev Med Vet Pays Trop. 1994;47(4):397-400.
The efficacy of Cymelarsan, administered by intramuscular (i/m) injection in the treatment of chronic cases of camel trypanosomosis due to Trypanosoma evansi, was tested under controlled laboratory conditions. It was confirmed that Cymelarsan is a safe drug for use in dromedary camels when administered i/m at dose rates of 0.25 or 0.50 mg/kg body weight. During the 90 days post-treatment no relapses occurred at either dose rate. Hence, the drug was found to be fully effective against the chronic form of the natural disease. A dose of 0.25 mg/kg body weight of Cymelarsan given i/m is recommended.
在可控的实验室条件下，对通过肌肉注射给予 Cymelarsan 治疗因伊氏锥虫引起的骆驼慢性锥虫病的疗效进行了测试。已证实，当以 0.25 或 0.50 毫克/千克体重的剂量通过肌肉注射给药时，Cymelarsan 是一种用于单峰骆驼的安全药物。在治疗后的 90 天内，两种剂量率均未出现复发情况。因此，发现该药物对自然疾病的慢性形式完全有效。建议肌肉注射给予 0.25 毫克/千克体重的 Cymelarsan 剂量。
